| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cryoport, Inc. | Director | Common Stock | 113K | $1.51M | $13.41 | May 17, 2024 | Direct |
| BIOVIE INC. | Director | Common Stock | 69.2K | $117K | $1.69 | Nov 9, 2023 | Direct |
| Celularity Inc | Director | Stock Option Grant (Right to Buy) | 118K | Aug 27, 2024 | Direct | ||
| Context Therapeutics Inc. | Director | Stock Option (right to buy) | 50K | Jun 13, 2024 | Direct | ||
| Frontier Investment Corp | Director | Ordinary Shares, $0.0001 par value | 31.3K | Jun 30, 2021 | Indirect economic interest for the value of the identified amount of shares. | ||
| Cryoport, Inc. | Director | Option (Right to Buy Common Stock) | 23.8K | May 17, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CELU | Celularity Inc | Aug 27, 2024 | 1 | $0 | 4 | Aug 28, 2024 | Director |
| CELU | Celularity Inc | Aug 27, 2024 | 0 | $0 | 3 | Aug 28, 2024 | Director |
| CNTX | Context Therapeutics Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| CYRX | Cryoport, Inc. | May 17, 2024 | 2 | $0 | 4 | May 21, 2024 | Director |
| CYRX | Cryoport, Inc. | May 15, 2024 | 1 | -$109K | 4 | May 16, 2024 | Director |
| SIDU | Sidus Space Inc. | Jan 18, 2024 | 0 | $0 | 3 | Jan 24, 2024 | Director |
| BIVI | BIOVIE INC. | Nov 9, 2023 | 1 | $0 | 4 | Dec 6, 2023 | Director |
| BIVI | BIOVIE INC. | Aug 22, 2023 | 1 | -$37.8K | 4 | Aug 24, 2023 | Director |
| CNTX | Context Therapeutics Inc. | May 31, 2023 | 1 | $0 | 4 | May 31, 2023 | Director |
| BIVI | BIOVIE INC. | May 22, 2023 | 2 | -$67.3K | 4 | Jun 15, 2023 | Director |
| CYRX | Cryoport, Inc. | May 12, 2023 | 2 | $0 | 4 | May 16, 2023 | Director |
| CYRX | Cryoport, Inc. | May 11, 2023 | 1 | -$155K | 4 | May 12, 2023 | Director |
| BIVI | BIOVIE INC. | Mar 27, 2023 | 3 | -$93.6K | 4 | Apr 6, 2023 | Director |
| CYRX | Cryoport, Inc. | Dec 1, 2022 | 1 | -$142K | 4 | Dec 5, 2022 | Director |
| BIVI | BIOVIE INC. | Nov 23, 2022 | 1 | $0 | 4 | Jan 18, 2023 | Director |
| CYRX | Cryoport, Inc. | Aug 16, 2022 | 1 | -$117K | 4 | Aug 16, 2022 | Director |
| CNTX | Context Therapeutics Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| CYRX | Cryoport, Inc. | Apr 29, 2022 | 4 | $0 | 4 | May 3, 2022 | Director |
| BIVI | BIOVIE INC. | Apr 5, 2022 | 1 | $0 | 4 | Apr 20, 2022 | Director |
| CNTX | Context Therapeutics Inc. | Oct 19, 2021 | 0 | $0 | 3 | Oct 19, 2021 | Director |
| CYRX | Cryoport, Inc. | Sep 13, 2021 | 7 | -$1.2M | 4 | Sep 15, 2021 | Director |
| FICV | Frontier Investment Corp | Jun 30, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Director |
| CYRX | Cryoport, Inc. | Apr 30, 2021 | 2 | $0 | 4 | May 7, 2021 | Director |
| BIVI | BIOVIE INC. | Jan 2, 2020 | 3 | $0 | 4 | Sep 29, 2021 | Director |
| BIVI | BIOVIE INC. | Jun 24, 2019 | 0 | $0 | 3 | Sep 28, 2021 | Director |